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Abstract
Genome-wide association studies (GWAS) are a valuable approach to understanding the genetic basis of complex traits. One
of the challenges of GWAS is the translation of genetic association results into biological hypotheses suitable for further
investigation in the laboratory. To address this challenge, we introduce Network Interface Miner for Multigenic Interactions
(NIMMI), a network-based method that combines GWAS data with human protein-protein interaction data (PPI). NIMMI
builds biological networks weighted by connectivity, which is estimated by use of a modification of the Google PageRank
algorithm. These weights are then combined with genetic association p-values derived from GWAS, producing what we call
‘trait prioritized sub-networks.’ As a proof of principle, NIMMI was tested on three GWAS datasets previously analyzed for
height, a classical polygenic trait. Despite differences in sample size and ancestry, NIMMI captured 95% of the known height
associated genes within the top 20% of ranked sub-networks, far better than what could be achieved by a single-locus
approach. The top 2% of NIMMI height-prioritized sub-networks were significantly enriched for genes involved in
transcription, signal transduction, transport, and gene expression, as well as nucleic acid, phosphate, protein, and zinc
metabolism. All of these sub-networks were ranked near the top across all three height GWAS datasets we tested. We also
tested NIMMI on a categorical phenotype, Crohn’s disease. NIMMI prioritized sub-networks involved in B- and T-cell
receptor, chemokine, interleukin, and other pathways consistent with the known autoimmune nature of Crohn’s disease.
NIMMI is a simple, user-friendly, open-source software tool that efficiently combines genetic association data with biological
networks, translating GWAS findings into biological hypotheses.
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Introduction
Genome-wide association studies (GWAS) have greatly facili-
tated the identification of genes involved in complex phenotypes
[1,2]. However, replication of association findings has often been
difficult, probably reflecting the relatively small effects of
individual markers, and the genetic heterogeneity of complex
traits [3]. The critical challenge now is to understand how
multiple, modestly-associated genes interact to influence a
phenotype [4–6]. Many studies have shown that there is a strong
relationship between gene function and phenotype, and that
functionally-related genes are more likely to interact [7–18].
Inspired by this insight, we undertook a systems-biology approach
to identify and prioritize groups of functionally-related genes that
are enriched for genetic variants associated with a trait, what we
call ‘trait prioritized sub-networks.’
Previously described network and pathway-based methods of
GWAS data are useful, but have limitations. Most 1) use licensed
software, which is often costly and lacks transparency [19–22]; 2)
depend on publicly available pathway databases that rely on a
limited number of available pathways (,500) and that often ignore
protein-protein interactions (PPIs) for recently studied genes [23–
30]; 3) rely on simulated or model organism data only [11,31]; 4)
require knowledge of programming [32]; or 5) limit the number of
input genes [33]. Since signals with small effects not detectable at
conventional levels of significance may account for substantial
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24220heritability [34], methods that can include all signals without
arbitrary thresholds of statistical significance are needed. Such
methods should extract more information from GWAS data by
identifying susceptibility genes that have functional similarity. We
hypothesized that such an approach might lead to a higher rate of
replication in independent datasets, compared to studies that rely
only on single markers. Replicated findings are more likely to
generate sound biological hypotheses for subsequent laboratory
studies.
To this end, we developed a novel software tool called Network
Interface Miner for Multigenic Interactions (NIMMI). This tool
generates biological networks using human PPI data, where
proteins are considered as nodes and the interactions between
proteins as edges. NIMMI assumes that proteins that show more
interactions with other proteins in the same network (i.e., have
higher connectivity) are more important than proteins with fewer
interactions, and weights each protein by use of a modification of
the Google PageRank algorithm [35]. This algorithm ranks
proteins in much the same way as the popular search engine ranks
websites on the internet, giving greater weight to proteins with
more connections to other proteins, especially those that are
themselves highly linked to additional proteins. Unlike the original
Google PageRank algorithm, this modified algorithm uses the PPI
data to calculate a ‘‘damping factor’’ dynamically for every gene in
a network, accounting for differences in the topology of biological
networks compared to computerized networks. To our knowledge,
this approach has never been tested on biological networks.
NIMMI combines these weights with the association signals from a
GWAS to identify trait prioritized sub-networks. In this study we
tested NIMMI in three GWAS datasets analyzed to assess genetic
contributions to height, a classical polygenic trait. We further
validate the method in a categorical phenotype, Crohn’s disease.
The results demonstrate that NIMMI can effectively identify genes
involved in quantitative and categorical traits and group them into
biologically-plausible networks that are highly replicable across
independent studies.
Results
Summary of the statistical approach
NIMMI is a network-based approach that relies on three basic
assumptions: 1) Genes, rather than SNPs are the functional units
in biology; 2) Genes do not work in isolation, thus genes whose
protein products show more interactions with other proteins in the
same network (i.e., higher connectivity) are more important than
proteins with fewer interactions; and 3) genetic association results
for a trait and protein interactions within a network are
complementary forms of information, reflecting a role for that
network in that trait [36–38].
NIMMI prioritizes biological networks in three key steps. First
networks are identified by use of human interactome data.
Proteins are represented as nodes and interactions are represented
as edges. Here we assumed that each gene corresponds to a single
protein and used human protein-protein interaction (PPI) data to
build the networks, but in principle any data that relates one gene
to another could be used. Each gene in the same network is
assigned a weight (wi) based on connectivity to other genes in the
same network, using a modification of the Google PageRank
algorithm. Second, gene-based association p-values are calculated.
Here we applied the Versatile Gene-based association study tool
(VEGAS) (http://gump.qimr.edu.au/VEGAS/) [39] to GWAS
data, but any method for mapping a SNP to a gene could be used.
The gene-based p-value was converted to a z-score (zi) and
combined with wi to generate the network-weighted score for that
gene. We used the Liptak-Stouffer method, which allowed us to
weight the association p-value by the square-root of the sample
size. Third, high-scoring genes are combined into what we call
‘trait prioritized sub-networks’, which were further tested by
DAVID (http://david.abcc.ncifcrf.gov/) [40,41], a publicly avail-
able bioinformatics tool that identifies functionally related groups
of genes. A flowchart of NIMMI’s analysis steps is shown in
Figure 1.
Comparison of single-locus method with NIMMI systems
approach
In order to compare ranking by single-locus analysis with
NIMMI, three independent height GWAS datasets were analyzed
using both single-locus ranking and NIMMI network ranking
methods. Percentile ranks of 34 candidate genes for height that
were deemed confirmed candidates in recent review of GWAS for
height were used as a standard of comparison [42–44].
The relative ranking of genes based on gene-wise association p-
values alone was highly sample dependent, and ranks varied
substantially in each GWAS dataset (Figure 2a). For the three
height GWAS datasets we present the association p-values of
susceptibility genes, gene-wise ranking, gene-wise percentile ranks
(gene-wise PR), NIMMI-network ranking and NIMMI percentile
ranks (Network PR) in Table S1. In contrast, the NIMMI-network
ranking was very stable for 95% of the genes, despite differences in
sample size and ancestry among the three height datasets
(Figure 2b). Most of the confirmed height-associated candidate
Figure 1. NIMMI flowchart. An overview of the dataflow in NIMMI is
shown in Figure 1. The data shown here is drawn from the InCHIANTI
height GWAS dataset. Approximately 2.5 million SNPs were analyzed
using PLINK setting the parameters as specified under GWAS data
module (see Design and Implementation). This resulted in ,2.4 million
SNPs with association p-values, which were then assigned to 17,783
genes. Gene assignment and gene-based p-values were calculated
using VEGAS. These gene-based p-values were converted to z-scores
and combined with gene weights (calculated by the modified Google
PageRank algorithm) in the network using the Liptak-Stouffer method
to identify the ‘trait prioritized sub-networks’ that were evaluated in
DAVID.
doi:10.1371/journal.pone.0024220.g001
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nd–5
th percentile of the NIMMI
ranking, and 95% of the genes fell in the top 20
th percentile of all
three datasets. For example, SCMH1 and CDK6, which belong to
the same PPI network, were consistently ranked in the 1
st
percentile in all three datasets. This demonstrates that NIMMI’s
gene ranks are highly replicable and more stable across
populations than those based on gene-based association p-values
alone.
Identification and prioritization of ‘trait prioritized sub-
networks’ for height GWAS datasets
Since 50% of the confirmed height-associated candidate genes
(shown in Figure 2b) consistently fall in the top 2% of the NIMMI-
ranked networks, these networks were compared in the three
height datasets. A total of 38 ‘height prioritized sub-networks’ were
generated, which consistently replicated across the three datasets
(Figure 3). There were 7 to 10 sub-networks that appeared to be
specific to each dataset and 4 to 7 sub-networks that were common
to any two datasets. The 38 height prioritized sub-networks
common to all three datasets were further evaluated for gene-set
enrichment using DAVID.
For each NIMMI prioritized sub-network, the p-values
(corrected for the total number of genes in a GWAS and for the
total number of networks in each of the datasets) are presented in
Table S2. A maximum of two significant Gene Ontology (GO)
terms generated by DAVID are shown, along with the specific GO
term, the number of genes associated with that GO term, and the
corrected gene-set enrichment p-value (see Methods for GO term
selection criteria). For example, one sub-network includes a total of
129 genes, of which 76 genes are involved in gene expression and
56 are involved in nucleic acid metabolism. Nineteen of the 38
sub-networks prioritized by NIMMI were significantly enriched
for genes involved in nucleic acid metabolism. Eight sub-networks
were enriched for genes that regulate gene expression and 12 sub-
networks were enriched for zinc metabolism. Other associated GO
terms implicated by NIMMI were transcription, signal transduc-
tion, transport, and phosphate and protein metabolism. Four sub-
networks were excluded because they were not associated with any
GO terms (not shown in Table S2).
NIMMI analysis of randomized data
Some networks identified by NIMMI may represent general
relationships among well-studied genes that arise frequently due to
‘‘small-world’’ effects. To estimate the impact of this phenomenon
in our data, we re-analyzed the height GWAS datasets after
randomization by two methods: 1. Randomization of the network
nodes; and 2. Permutation of gene labels in the GWAS data. Two
sub-networks appeared consistently in the random networks
Figures 2. Comparison of gene-based percentile ranks with NIMMI’s network percentile ranks. The x-axis shows the candidate genes for
height and the y-axis shows the percentile rank. Blue triangles represent the InCHIANTI GWAS dataset, red squares represent the Korean height GWAS
dataset and green circles represent the GAIN Controls height GWAS dataset. Figure 2a shows the single-locus ranking and Figure 2b shows NIMMI
network-based ranking for 34 height candidate genes.
doi:10.1371/journal.pone.0024220.g002
Network Interface Miner Multigenic Interactions
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24220analysis. Eight additional sub-networks appeared in .50% of
NIMMI runs performed on the randomized GWAS results (Table
S3). NIMMI analysis of randomized data is thus an important step
in the identification of sub-networks that are most deserving of
further study.
Comparison of NIMMI prioritized height sub-networks
with Cytoscape
The three height GWAS datasets were also analyzed in
Cytoscape using jActive modules and BiNGO plugins (as
described in Baranzini et al [33]). Table 1 shows the 9 GO terms
that were prioritized by either NIMMI or Cytoscape. There was
substantial agreement between the two methods, with 7 out of 9
GO terms identified by both methods.
Identification and prioritization of Crohn’s disease sub-
networks by NIMMI
To test the performance of NIMMI with a categorical trait, we
analyzed a published GWAS based on a case-control sample
studied for Crohn’s disease, an autoimmune disorder that has
yielded about 20 risk loci by GWAS. NIMMI prioritized nine sub-
networks that were significantly enriched for the GO terms
‘‘apoptosis’’, ‘‘response to organic substance’’, ‘‘intracellular
signaling’’, ‘‘gene expression’’, ‘‘nucleic acid metabolism’’, ‘‘RNA
metabolism’’, and ‘‘protein metabolism’’ (Table 2). KEGG and
BioCarta pathway analysis of these nine prioritized sub-networks
showed significant enrichment of apoptosis, B-cell receptor, T-cell
receptor, chemokine, IL-2, IL-6, Jak-STAT, Wnt and TPO
signaling pathways. These results are consistent with the known
autoimmune nature of Crohn’s disease. A complete list of
significantly enriched pathways is presented in Table 3.
Discussion
NIMMI is a simple and efficient software tool that allows
researchers to prioritize their GWAS results based on the
functional relationships of the associated genes. To our knowledge,
NIMMI is the first software tool that maps all the genes in a
GWAS dataset to human interactome data using a modified
Google PageRank algorithm. With NIMMI it is possible to
identify ‘trait prioritized sub-networks’ in complex, multigenic
traits and thus provide biological hypotheses for further study.
We hypothesized that NIMMI would produce more robust
findings than single-locus analyses. To test this hypothesis, NIMMI
was run on three independent samples rated for the classic
polygenic trait of height. NIMMI produced a list of genes with
very consistent ranking across all 3 datasets. This level of
reproducibility was not achieved with gene-based analysis,
probably reflecting small effect sizes of individual loci and differing
sample sizes, reducing power to detect true signals. Despite
population and sample size differences, NIMMI also identified
networks that were enriched with confirmed height associated
candidate genes. Furthermore, when height associated candidate
genes were analyzed in DAVID, there were no significantly
enriched GO terms suggesting that the functional relationships
between genes that NIMMI networks represent could not be
identified with single-locus analyses alone.
NIMMI’s approach is unique. Previous studies that have used
the Google PageRank algorithm to rank genes in a network relied
on fixed damping factor values (0.5#d#0.95) (see Methods)
[45,46,47]. Research by Fu et al has shown that a fixed damping
factor can result in inconsistent ranking of the nodes in a network.
Given that a flexible damping factor is needed, one of the natural
approaches is to calculate it dynamically by using the ratio of
interactions between neighboring genes [35]. Hence, NIMMI
calculates the damping factor dynamically for every gene in a
network which may be more appropriate for biological networks
than the fixed damping factor typically used for ranking pages on
the internet.
Most of the literature published on network and pathway-based
approaches has focused on statistically significant findings from
Figure 3. Network overlap. Top 2% overlap of NIMMI prioritized
networks in InCHIANTI, Korean and GAIN controls datasets shows 38
networks that are common to all three datasets. Five networks are
common to InCHIANTI and GAIN controls datasets only. Korean and
GAIN controls datasets have seven networks in common and four
networks are common between InCHIANTI and Korean datasets. Ten
networks are specific to InCHIANTI dataset, whereas Korean and GAIN
controls datasets have 8 and 7 networks, respectively.
doi:10.1371/journal.pone.0024220.g003
Table 1. NIMMI ’height prioritized sub-networks’ vs.
Cytoscape.
GO-terms* NIMMI sub-networks Cytoscape sub-networks
Ex x
Hx
Mx x
Nx x
Px x
Rx x
Sx x
Tx x
Zx
*E-Gene Expression; H - Steroid Hormone receptor signaling; M-Protein
metabolic process/protein modification process; N-Nucleic acid metabolism/
Nucliec acid binding/DNA-Replication; P-Phosphate/phosphorus metabolic
process; R-RNA processing/RNA binding/RNA metabolic process/RNA splicing/
Transcription/Transcription Regulation; S-Signal transduction/Intracellular
signaling/Cell communication; T-Transport/localization; Z-metal ion binding/
zinc ion binding.
doi:10.1371/journal.pone.0024220.t001
Network Interface Miner Multigenic Interactions
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24220GWAS studies for replication or for downstream analysis
[20,21,25,27,28,33], [48]. These studies are limited by the
problem of finding an optimal p-value threshold. If the p-value
threshold is set too low, then the number of genes might be too few
to create a biological network and to find associated pathways
[49]. Sets of findings with higher p-value thresholds, on the other
hand, will contain more false positives. The magnitude of this
problem was illustrated by the results of the International
Schizophrenia GWAS Consortium, where optimal discrimination
between cases and controls was achieved only after the inclusion of
over 70,000 markers with p-values as high as 0.2 [34]. A major
advantage of NIMMI’s approach is that it includes all the findings
in a GWAS dataset, weighting the findings by p-value and other
factors that users may specify (such as effect size). This reduces the
‘‘top hits’’ selection bias. An example may illustrate this point. The
gene BMP2, which encodes bone morphogenetic protein 2, has
been implicated in several height GWAS studies [42], but it is not
significant in any of the GWAS datasets used in the current study
(gene-wise p-values of 0.57, 0.61 and 0.27). Although BMP2 plays
a major role in bone development, this gene would not have been
selected for downstream analysis with the classical p-value
approach. However, NIMMI’s network ranking correctly places
this gene in the top 1
st–3
rd percentile. This is because NIMMI
takes advantage of signals in genes whose protein products interact
with BMP2, making NIMMI sensitive to statistical significance in
any individual dataset.
The goal of NIMMI is to prioritize networks for further study.
To aid decisions as to which networks to pursue, NIMMI can be
applied to randomized networks and GWAS data. Of the 38
‘height prioritized sub-networks’ that successfully replicated in the
three GWAS datasets, 2 appeared consistently in the random
networks analysis, suggested that the Type I error rate was about
5% at the network level. When NIMMI was used to analyze
10,000 randomized GWAS datasets, a number of sub-networks
appeared in .50% of the results sets (Table S3). We suggest that
the users assess their own results in this way and ignore sub-
networks that occur frequently in the results derived from
randomized data. It is likely that such sub-networks represent
general relationships among well-studied genes that arise fre-
quently due to ‘‘small-world’’ effects. Sub-networks that occur
rarely in the results derived from randomized data appear to have
good trait specificity. For example, 16 height-prioritized sub-
networks that were observed in ,5% of the randomized results
included 7 sub-networks that were significantly enriched for zinc
metabolism. This GO term was enriched only for height and not
Crohn’s disease. Zinc plays an important role in human growth.
Studies in rats and tissue culture confirm that zinc stimulates DNA
synthesis and protein synthesis in bone development [50,51].
Furthermore, zinc is a co-factor for zinc finger proteins that bind
to methylated DNA to suppress transcription, thus regulating gene
expression and protein synthesis [52].
Other GO terms significantly enriched among the height-
prioritized sub-networks include nucleic acid metabolism, tran-
scription, gene expression, signal transduction and transport,
proteosome and protein metabolism. The effects of growth
hormone on protein metabolism are well-documented in the
literature, in both human and animal models. These studies
suggest that growth hormone stimulates protein synthesis and
decreases protein catabolism, a process that mainly occurs in the
proteosome [53–56]. Additionally, keywords such as gene
expression, signaling and proteases have recently been associated
with height markers by GRAIL [57], a statistical text mining
approach. Although most of the NIMMI detected ‘height
prioritized sub-networks’ are well-supported by the literature,
further functional studies are required to confirm these results.
NIMMI is reasonably sensitive in detecting true trait-related
genes. For example, Table S1 includes 34 height associated genes,
16 of which were among the 1,232 genes identified within the top
2% of height prioritized sub-networks by NIMMI. This is a highly
significant overlap, given that the total number of genes in all sub-
networks created by NIMMI is 6035 (p-value=1.11610
24,
hypergeometric test). Although 38 sub-networks were prioritized
for height, there is substantial overlap among these sub-networks
(75%-90%). Each functional category consists of #100 genes.
There is also overlap of genes between functional categories. For
example, the category ‘‘gene expression’’ (E) includes ,100 genes,
and ‘‘transcription’’ (R) includes ,75 genes, but at least 50% of
the genes in set E overlap with those in set R.
Some of the functional categories (nucleic acid metabolism,
gene expression) overlap between height and Crohn’s disease
prioritized sub-networks. These are broad categories and may
reflect a true pathway overlap for these two otherwise disparate
Table 2. NIMMI prioritized sub-networks for Crohn’s Disease.
Crohn’s
Disease
Bonf.
corrPval
David
GO
Set 1*
Genes
in
Set1
Enrichment
Pval
David
GO
Set 2*
Genes
in
Set2
Enrichment
Pval
David
GO
Set 3*
Genes
in
Set3
Enrichment
Pval
9.51E-14 A 29/96 3.50E-08 N 31/96 7.30E-05 M 26/96 1.90E-10
2.12E-13 27/107 1.90E-03 33/107 1.70E-03 R 27/107 4.40E-11
3.30E-13 28/110 2.60E-03 O 27/110 1.00E-06 S 38/110 1.50E-07
3.53E-13 30/91 7.30E-07 23/91 4.90E-04
3.23E-16 R 65/115 1.90E-20 O 28/115 4.90E-04 E 35/115 3.80E-15
4.10E-13 74/152 2.50E-18 N 41/152 9.00E-15 S 38/152 1.50E-04
2.89E-13 N 31/89 9.40E-05
2.08E-14 31/123 1.80E-02
A-Apoptosis; E-Gene Expression; M-Protein metabolic process/protein modification process; N-Nucleic acid metabolism/Nucliec acid binding/DNA-Replication; O-
response to organic substance; R-RNA processing/RNA binding/RNA metabolic process/RNA splicing/Transcription/Transcription Regulation; S-Signal transduction/
Intracellular signaling/Cell communication.
doi:10.1371/journal.pone.0024220.t002
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metabolism and transport, were specific to height. Several
functional categories were specific to Crohn’s disease, including
apoptosis, response to organic substance, Jak-Stat signalling and
autoimmune pathways (B-cell receptor, T-cell receptor signalin-
g,etc), consistent with the auto-immune nature of this disease.
Although these pathways were detected by other studies [59],
additional research is necessary to confirm the NIMMI results in
additional samples.
Comparison of NIMMI prioritized height sub-networks to those
from Cytoscape jActive modules illustrate that NIMMI gave
similar results to the greedy algorithm implemented in Cytoscape.
A major limitation of Cytoscape jActive modules is that it requires
the input gene set be limited to those with p-value #0.05. NIMMI
considers all genes implicated in a GWAS dataset, with no p-value
threshold required. Consideration of all genes in the network
analysis is important because GWAS p-values are inconsistent,
especially when sample sizes are small. Including all genes in the
Cytoscape analysis resulted in more than 1500 significantly
associated GO terms, some of which could be false positives.
Furthermore, NIMMI prioritizes trait networks within 3 seconds,
which is 10 times faster than what we could achieve with
Cytoscape. Cytoscape jActive modules and BiNGO also need
more user intervention and formatting than is ordinarily necessary
for NIMMI.
The goal of GWAS is to help illuminate the underlying
molecular mechanism of a particular phenotype. To maximize the
information provided by a GWAS, it is important to integrate
functional data with GWAS results. NIMMI is a user-friendly
software tool that will help researchers in their post-GWAS
decisions by prioritizing genes and networks that are of the highest
biological relevance.
Limitations
Some important limitations of network and pathway-based
approaches should be mentioned. SNPs do not always bear a clear
relationship to a particular gene, and may occur in non-genic
regions. Some widely studied genes appear to have relatively
greater connectivity, while less studied genes have less, due largely
to publication bias. PPIs are sometimes inconsistent, or tissue
dependent. Functional annotation systems, such as GO, have not
yet been experimentally confirmed for most genes. In spite of these
limitations, network and pathway-based approaches provide a
unique insight into biology that is often not immediately evident in
the GWAS results. As additional genome-wide functional studies
are completed in the field, the quality of network and pathway
information is likely to improve [29,60–63].
Conclusions
NIMMI is an open-source tool that takes into account
information on biological relationships to help interpret GWAS
data and to prioritize trait networks for further study. NIMMI
offers several advantages over other network and pathway-based
approaches. The results of this study demonstrate that NIMMI
can identify important genes involved in a multi-genic trait with a
high degree of consistency and reproducibility, even across
datasets of differing size and ancestry.
The main aim of NIMMI is to help investigators prioritize genes
and networks related to a particular phenotype after a GWAS.
Although there are limitations to this approach, protein-protein
networks and pathways are an excellent source of biological
information that, when combined with genomics, could lead to a
better understanding of molecular mechanisms. NIMMI efficiently
combines genetic association data with protein networks, thus
helping to effectively translate GWAS findings into biological
hypotheses.
Materials and Methods
Height GWAS datasets
A total of three independent GWAS height samples were
analyzed by NIMMI.
The Invechhiare in Chianti (InCHIANTI) GWAS da-
taset. The InCHIANTI Study is a population-based epidemio-
logical cohort study in the Chianti region of Tuscany, Italy. The
study employs two clinical sites, in the towns of Greve and Bagno a
Ripoli, with participants recruited from the population registries of
these immediate areas. Further details on this cohort have been
previously published elsewhere [64]. DNA extracted from
InCHIANTI participants was genotyped at the Laboratory of
Neurogenetics, National Institute on Aging, using Illumina 550K
beadchips. After standard QC measures, missing genotypes were
imputed using MACH 1.0 software (http://www.sph.umich.edu/
csg/abecasis/mach/) [65]. Maximum likelihood genotype dosages
were filtered for quality of imputation prior to analysis (R
2 from
MACH.0.30). Analyses were conducted on 975 unrelated
members of the InCHIANTI cohort who had height data within
+/-3SD from the mean of the sample. After outliers were removed
height was log transformed. PLINK (http://pngu.mgh.harvard.
Table 3. NIMMI prioritized Crohn’s Disease enriched KEGG/
BioCarta pathways.
enriched KEGG/BioCarta pathways enrichment p-value
Adherens junction 8.70E-07
Apoptosis 3.50E-05
B-cell receptor signaling 1.10E-02
Cell cycle 1.70E-07
Chemokine signaling 9.90E-03
Control of gene expression by vitamin D receptor 1.30E-07
EGF signaling 7.60E-04
ErbB signaling 8.10E-06
Erk1/Erk2 Mapk signaling 9.20E-05
Fc gamma R-mediated phagocytosis 5.80E-14
Focal adhesion 3.20E-06
IL-2 Receptor Beta Chain in T cell Activation 1.60E-02
IL6 signaling 2.80E-03
Insulin signaling 2.90E-04
Jak-STAT signaling 2.70E-03
Neurotrophin signaling 1.20E-02
p53 signaling 1.20E-03
Pathways in cancer 6.30E-11
Pelp1 Modulation of Estrogen Receptor Activity 1.20E-04
Role of PPAR-gamma Coactivators in Obesity
and Thermogenesis
2.40E-04
T Cytotoxic Cell Surface Molecules 8.00E-03
T-cell receptor signaling 1.50E-04
TPO signaling 7.30E-03
Wnt signaling 1.70E-03
doi:10.1371/journal.pone.0024220.t003
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[66], was used for association analysis using study site and sex as
covariates, resulting in a ,2.4 million SNPs after pruning.
Genomic control inflation factor (l) was 1.008. A l close to 1
indicates that association of markers to the phenotype is real rather
than due to population stratification. A total of 17,783 genes with
gene-wise p-values were used in the downstream analysis (Table 4).
Korean GWAS dataset. Height GWAS data published by
Cho et al. were obtained from the researchers [67]. Unimputed
summary data for 8,842 Korean individuals was provided as well.
Age, sex and study site were used as co-variates in the PLINK
association analysis. l was 1.061 and ,350K SNPs were left after
pruning, resulting in 17,408 genes being analyzed by NIMMI
(Table 4).
Genetic Association Information Network (GAIN) Con-
trols GWAS height dataset. GWAS data for GAIN controls
was obtained from GAIN (http://www.genome.gov/19518664)
under a data access agreement. Self-reported height was available
for 768 individuals. Only sex was used as a co-variate and ,720 K
SNPs were left after pruning by PLINK. l was 1.059 and a total of
17,720 genes were used in the final analysis by NIMMI (Table 4).
Crohn’s disease (CD) GWAS dataset
Summary SNP association results for the CD GWAS dataset
(,2000 cases and ,3000 controls) was obtained from the
Wellcome Trust Case Control Consortium (WTCCC). Association
analysis results are detailed elsewhere [68]. Approximately 409 K
SNPs with their association p-values were assigned to 17,114 genes
that were included in NIMMI network analysis (Table 4).
Algorithm
Modified Google PageRank Algorithm. Each protein in a
network was considered a node, and the interactions between
proteins were considered edges, resulting in an undirected graph.
Some of the centrality measures available to rank networks are: 1)
Degree centrality, which simply counts the number of interactions
to a node; 2) Betweenness centrality, where nodes which fall in the
shortest path of other nodes have high betweenness; 3) Closeness
centrality, which is related to the topology of the nodes in a
network; and 4) Eigenvector centrality which ranks the nodes in a
network based on the its interacting neighbors, i.e., it takes into
account the quantity and quality of connections to a particular
node [69,70]. For example, when ranking a webpage (wp),
Google’s PageRank algorithm not only considers the number of
connections a wp has, but also the connectivity of the pages linked
to wp. Therefore, wp will receive a higher rank if it is connected to
other highly ranked webpages. Since proteins in a biological
network should also be ranked based on the importance of their
interacting partners, scoring them by eigenvector centrality seems
to be a reasonable approach.
The PageRank algorithm, which is a based on eigenvector
centrality, starts by creating an adjacency matrix (A) for all the
proteins (nodes) in a network based on their interactions.
Ai,j=A j,i=1 if protein ‘i’ interacts with protein ‘j and vice versa,
else Ai,j=A j,i=0. According to the Perron-Frobenius theorem in
linear algebra, for a real square matrix with positive values there
exists a largest positive eigenvalue and a corresponding positive
dominant eigenvector [69]. The algorithm finds the dominant
eigenvector for this adjacency matrix via power iteration (Figure S1)
[45,71–73]. Thus, the  resulting dominant eigenvector values are
considered weights of proteins in a network.
The original Google PageRank algorithm suggested by
Lawrance Page and Sergey Brin had a damping factor of 0.85
and excluded dangling links (nodes that have only incoming links
but no outgoing links), before ranking the web networks. A
damping factor is essential because it improves the speed of the
algorithm and keeps it from hitting dead ends [74–77] (http://
www.miislita.com/information-retrieval-tutorial/matrix-tutorial-3-
eigenvalues-eigenvectors.html; http://www.webworkshop.net/
PageRank.html). Investigators who previously applied the Google
PageRank algorithm to rank SNPs or genes used a damping
factor between 0.5#d#0.95 [45,46]. The damping factor of 0.85
has been well evaluated for web networks and not for biological
networks. Additionally, Fu et al have shown that a fixed damping
factor value will lead to inconsistent ranking of nodes in a
network [35]. Since all biological networks are not the same,
having a fixed damping factor value for all networks might not be
ideal. Furthermore, dangling links should be included while
ranking a biological network. Given these limitations of the
original Google PageRank algorithm, we used the modified
Google PageRank algorithm suggested by Fu et al in 2006 [35] to
rank the proteins in each of our 2,849 networks (see Design and
Implementation).
Equation (1) depicts the modified Google PageRank algorithm
wa~ 1{
X
gi X
li
 !
x
1
2N
z
X
gi X
li
x
wg 1 ðÞ
l1
z
wg 2 ðÞ
l2
z...
wg n ðÞ
ln
  
ð1Þ
where,
wa =weight/PageRank of protein (gene) A in a network
g=all proteins that interact with protein A
Table 4. Summary of GWAS datasets.
Height Datasets n Observed [O] Imputed [I] SNPs after QC Total Genes
InCHIANTI 975 I 2,453,309 17,783
Korean 8,842 O 352,228 17,408
GAIN Controls 768 O 722,742 17,720
Crohn’s Disease Cases Controls Observed [O] Imputed [I] SNPs after QC Total Genes
WTCCC Crohn’s 1,748 2,953 O 409,541 17,114
doi:10.1371/journal.pone.0024220.t004
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li =sum of all proteins that interact with ‘g’ proteins
Xgi
li
=damping factor, which is the ratio of total proteins ‘g’
that interact with protein A to the sum of all proteins that interact
with ‘g’ proteins
wg 1 ðÞ ,wg 2 ðÞ ,...wg n ðÞ =weight/PageRank of proteins H1 to
Hn that interact with protein A
l1,l2,...ln =proteins that interact with proteins g1,g 2,…… gn
respectively
N =Total number of proteins in the network
The advantage of using the modified formula is that it
considers all nodes in the network without any exclusion, and that
the damping factor is calculated dynamically for every node in a
network based on its interactions with neighboring nodes, making
it more optimal to rank biological networks. Such an approach
results in a damping factor value that is better reflective of the
network. To scale the total probability of a given network
between 0 and 1, the N in the above formula was doubled. Each
protein in a network has a weight ranging between 0 and 1. The
protein with weight closer to 1 plays an important role in the
network than a protein with weight closer to 0, indicating that the
higher the weight the higher the importance of a node in a
network.
The Liptak-Stouffer method. The gene-wise association
p-value, which is calculated by VEGAS, was integrated with
gene weight (obtained from the modified Google PageRank
algorithm) in a network. While several approaches are possible,
for simplicity we chose the Liptak-Stouffer method. This
method of combining p-values from independent experiments
has previously been used in the analysis of genome-wide gene
expression data [78-80] among others. At first, the association
p - v a l u eo fe a c hg e n ew a sc o n v e r t e dt oi t sc o r r e s p o n d i n gz - s c o r e
as calculated in equation (2):
zi~
pi{m
s
ð2Þ
where,
zi =z-score of a particular gene
pi =empirical gene-wise p-value of a particular gene in a given
GWAS dataset
m=mean of all the p-values in a given GWAS dataset
s=standard deviation of the p-values in a given GWAS dataset
Then, a combined z-score for a network was calculated using
the Liptak-Stouffer formula shown in equation (3):
Zcomb~
Xn
i~1 wizi ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ Xn
i~1 w2
i
q ð3Þ
where,
Zcomb =combined Z-score of a given network
wi =weight of the protein (gene) obtained from modified Google
PageRank in a given network
zi =association z-score of the gene obtained from GWA data
n=number of proteins (genes) in a given network
Usually, the ‘‘wi’’ in the Liptak-Stouffer formula refers to
sample-size. However, we assigned gene weights based on the
modified Google PageRank algorithm. A justification is provided
in Methods S1 and Figure S2. The Zcomb is then transformed into
its corresponding p-value and corrected for the number of genes in
a network and total number of networks (by Bonferroni
correction).
Architecture of Network Interface Miner for Multigenic
Interactions (NIMMI)
NIMMI consists of three levels: SNPs, Genes and Networks.
Each level in turn has sub-modules (Figure 4). At the SNPs level
(or Level 1), the SNPs were analyzed in the GWAS data module,
which were then assigned to genes at GENES level (Level 2) using
VEGAS, a software tool. VEGAS also calculates a gene-based p-
value for each gene. The Database Miner and Network generator
module in Networks level (or Level 3) mined the BioGRID
database for human PPIs and created two-step networks that were
then ranked using the modified Google PageRank algorithm using
Gene/Network ranker module. An association gene-wise p-value
of a gene from VEGAS and gene weight from Gene/Network
ranker module were then combined using Liptak-Stouffer method.
The resulting ‘trait prioritized sub-networks’ were then evaluated
in DAVID.
Level 1: SNPs: GWAS data module. Individual population-
based samples from the ‘‘Invechhiare in the Chianti’’ (InCHIANTI)
study and Genetic Association Information Network (GAIN) were
genotyped on Illumina 550 K and Affymetrix 6.0 microarrays
respectively. Genotype information from these SNPs and phased
haplotype information on a reference dataset from the HapMap
Phase 2 CEU samples (http://hapmap.ncbi.nlm.nih.gov/) were
used to impute the allele frequencies of SNPs that are absent on
these microarrays. Imputation was performed using MACH 1.0
software. The resulting data were analyzed using PLINK. The
following criteria were applied while executing PLINK:
1. SNPs with minor allele frequency (MAF),1% were excluded.
2. SNPs that deviate from Hardy-Weinberg equilibrium (HWE)
may indicate genotyping errors [81–83]. Hence, SNPs with
HWE p-value,10
-5 were excluded.
3. SNPs with failure rate.2% were excluded.
4. Any individuals with.2% missing genotypes were excluded.
A summary statistics file (SNP name along with its association p-
value) of analyzed height GWA data was obtained from our
collaborators in Korea and a similar file for Crohn’s disease
GWAS dataset was obtained from WTCCC.
At the end of Level 1, GWA data consisted of a SNP name and
an association p-value which are annotated to their respective
genes in Level 2.
Level 2: GENES: Versatile Gene-based Association Study
(VEGAS). VEGAS is an open source software tool that assigns
SNPs from Level 1 to their respective genes based on their position
and calculates an empirical gene-based p-value using Monte Carlo
simulations (# 1 million) (http://gump.qimr.edu.au/VEGAS/)
[39]. Any SNP that falls within a 50 kb flanking region of a gene
will be assigned to that particular gene. Such an assignment will
capture the regulatory regions and SNPs in LD. Although this
value is arbitrary, it could be modified according to user
specification. When a SNP belongs to more than one gene, that
particular SNP was assigned to multiple genes in that location.
Given that the PPI data is incomplete, such an assignment allows
us to include all the possible genes with interaction data to be
included in our downstream analysis. The linkage disequilibrium
for each gene is estimated using HapMap populations. For
InCHIANTI and GAIN controls height GWAS dataset, and CD
GWAS dataset CEU population was used as a reference dataset,
whereas CHB_JPT was used as a reference for Korean height
GWAS dataset.
Level 3: NETWORKS. This level is made up of a Database
Miner and Network generator module and a Gene/Network
Ranker and prioritizer module. (1) Database Miner: The entire
Network Interface Miner Multigenic Interactions
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downloaded from the Biological General Repository for
Interaction Datasets (BioGRID) database (http://www.
thebiogrid.org/). After excluding human-nonhuman PPIs, a total
of 38,509 human-human PPIs were left. Any PPIs detected by
different experimental methods were integrated and self
interacting proteins were deleted resulting in 24,101 unique
human-human PPIs involving 7,646 unique proteins. These
unique interactions were used to build biological networks. (2)
Network generator: In the human PPI network, proteins are
represented as nodes and the interaction between proteins are
represented as edges. In order to find the optimal number of
proteins per network, networks were created using single-step,
two-step and three-step methods (data not shown). The median
number of proteins per network with a single-step is three (too few)
and with three-step was found to be 815 (too large). However, the
median number of proteins per network created by two-step
process was 58; this is an optimal number for computational
efficiency as well as for the search space. A total of 7,646 networks
were created by the network generator using the two-step method
(Figure S3), of which 2,912 networks were complete subsets of
other networks. Hence, these were excluded in the downstream
analysis leaving 4,734 networks. These were then ranked using the
modified Google PageRank algorithm (see Algorithm). Each of the
4,734 networks had between two and 1000 proteins. To reduce the
search space, multiple-testing correction factor associated with the
number of proteins and number of networks, and to avoid any
false positive networks that could arise due to large size of the
networks, we included networks that have only 20–200 proteins
[29,48,84]. The algorithm was tested on various protein ranges in
InCHIANTI dataset; this also led to the conclusion that the
optimal range of proteins in a network is 20–200 (data not shown)
resulting in a total of 2,849 networks. (3) Gene/Network
Ranker module: The resulting 2,849 networks from above
Network generator module were ranked using the modified
Google PageRank algorithm (see Algorithm). (4) Network
Prioritizer module: In this module the association signals
were combined with gene weights using the Liptak-Stouffer
method (see The Liptak-Stouffer method).
Summary statistics module. In this module summary
statistics for each network were generated. These consisted of
names of significant genes and non-significant genes, number of
significant and non-significant genes; total number of genes in a
network; network number; combined Z-score (Zcomb); network p-
value and corrected p-value.
DAVID, a functional annotation tool. To evaluate results
obtained from NIMMI, genes in the top replicated networks were
submitted to DAVID, a functional annotation tool [40,41]. There
were a total of 7,646 unique proteins (genes) in BioGRID. The
official names of these genes were converted to Genbank
accession numbers and submitted as background to DAVID.
Of the 7,646 genes, DAVID found 6,327 genes and set them as
background. DAVID corrects the enrichment p-values for the
number of background genes submitted. Then genes belonging to
a particular network were submitted and results from the
functional annotation tool were selected based on the following
criteria:
N Each GO category should have at least 25% gene overlap with
the input list.
N Enrichment p-value for each GO term had to be significant
(p#0.05).
Figure 4. Architecture of Network Interface Miner for Multigenic Interactions (NIMMI). Network Interface Miner for Multigenic Interactions
(NIMMI) consists of three levels: SNPs, Genes and Networks, and each level in turn has different modules necessary to prioritize ‘trait prioritized sub-
networks’. At the SNPs level (or Level 1), the SNPs are analyzed in the GWAS data module using PLINK. The SNPs are then assigned to genes and a
gene-wise p-value is calculated using VEGAS (Level 2). The Database Miner and Network generator module in Networks level (or Level 3) mine the
BioGRID database for human PPIs and created two-step networks that are then ranked using the modified Google PageRank algorithm in the Gene/
Network ranker and prioritizer module. The association p-value of a gene from Level 2 and gene weight from Level 3 are then combined using the
Liptak-Stouffer method. The resulting ‘trait prioritized sub-networks’ are then evaluated in DAVID.
doi:10.1371/journal.pone.0024220.g004
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should be #0.05.
N Medium to high stringency level was selected.
N General GO terms like plasmamembrane, membrane, cyto-
plasm, intracellular, etc were excluded.
To keep the tables concise, the top two GO categories that fit
the abovementioned criteria were presented in the results.
Replication
Since NIMMI considers genes and networks as the functional
units rather than individual SNPs, replication is expected at the
gene/network level rather than at SNP level in the new sample.
To test this, the networks NIMMI identified for height in the
InCHIANTI GWAS dataset were tested in two independent
GWAS datasets (Korean and GAIN Controls) for height.
Randomization of networks
Networks were randomized by permutation of the node labels.
Although the number of nodes and edges per network remain the
same as the original network, the identities of the nodes were
changed resulting in randomization of the network. By this
randomization procedure hubs will not remain as hubs. We
performed 100 randomizations of the original networks.
Permuting GWAS data
In a given GWAS dataset the gene labels and the association p-
values were permuted and NIMMI analysis was performed on
each of the 10,000 permuted files.
Implementation of NIMMI
The user input file can either be in PLINK format (*.ped and
*.map files) or a summary file with marker names along with
association p-values. VEGAS then assigns these markers to their
respective genes and calculates a gene-wise association p-value.
The output file from VEGAS is then input to a perl script,
weightedZscore_forVegasFiles.pl, which converts the association
p-values to z-scores and integrates them with gene weights in
networks to obtain a combined Z-score for a network (Zcomb),
which is then converted to a p-value and corrected for the number
of tests. The implementation of the modified Google PageRank
algorithm in NIMMI has allowed it to identify ‘trait prioritized
sub-networks’ in a given dataset within three seconds.
Availability and Future Directions
NIMMI software along with user manual can be downloaded
from http://mapgenetics.nimh.nih.gov/datashare.html.
The current version of NIMMI includes only human PPIs, but
this could easily be extended to PPIs from other model organisms.
Future versions will incorporate gene expression data and micro
RNA studies, whenever available, which could help in further
pruning of the prioritized list of networks.
Supporting Information
Figure S1 Power iteration. An adjacency matrix was created
based on the links of all the proteins in a network. The power
iteration starts by initializing an eigenvector which is multiplied
with the adjacency matrix resulting in a new eigenvector. This new
eigenvector is normalized and multiplied with the original
adjacency matrix until the algorithm finds a dominant eigenvector
for this adjacency matrix.
(PDF)
Figure S2 Standard error of the mean versus network
size. The x-axis shows the number of genes in a network and y-
axis shows the standard error of the mean (SEM).
(PDF)
Figure S3 Constructing Two-step networks. Building a
two-step network starts with one protein-protein interaction
(protein1-protein2). In STEP1 all the proteins interacting with
protein1 and protein 2 are added to the network i.e., protein 3
interacts with protein 1 and protein 4 interacts with protein 1 and
protein 2, so it is linked to both these proteins. In STEP2 all
proteins interacting with proteins in STEP1 are added to the
network, for e.g., proteins 6, 7 and 8 interact with protein 4 and
protein 5 interacts with protein 3.
(PDF)
Methods S1 Rationale for using gene weight ‘‘wi’’ in
Liptak-Stouffer method.
(DOC)
Table S1 Comparison of single-locus ranking with
NIMMI network ranking.
(DOC)
Table S2 ‘Trait prioritized sub-networks’ for height.
(DOC)
Table S3 Empirical p-values of height-prioritized sub-
networks.
(DOC)
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